Ulipristal Acetate API powder
CAS NO.:126784-99-4
Molecular formula:C30H37NO4
EINECS:682-170-1
Synonyms:HRP 2000;VA 2914
Shelf life: 24 months
Purity : 98% HPLC
Certificate:COA; HPLC; MSDS; TDS,etc.
MOQ : 1g;10g;100g
Shipping: DHL/FedEx/UPS/USPS Safe and fast delivery
Lead Time: 1-3 days
Warehouse: USA and Germany warehouse
- Product Description
Xi'an Faithful BioTech Co., Ltd: Your Trusted Ulipristal Acetate API powder Manufacturer & Supplier
Xi'an Faithful BioTech Co., Ltdwas founded in 2018 and is located in Xi'an, Shaanxi Province. Faithful is a company specializing in the supply of active pharmaceutical ingredients and pharmaceutical intermediates. We supply Ulipristal Acetate API powder. We adhere to the business policy of "high quality at competitive prices, thoughtful service, and greater customer satisfaction" to ensure the provision of high-quality products and services to our customers. Sincerely invite friends from all walks of life around the world to inquire, cooperate sincerely, benefit from each other, and develop together.
Ulipristal Acetate API powder Introduction
Ulipristal Acetate API Powder is a novel oral emergency contraceptive, a progesterone agonist/antagonist, whose mechanism of action is to inhibit or delay ovulation. Mainly used for emergency contraception during unprotected sexual intercourse or contraceptive failure within 120 hours (5 days).The appearance is white powder, and compared with the most commonly used emergency contraceptive Levonorgestrel, Ulipristal Acetate has a wider applicability and the potential to prevent more unintended pregnancies.Our production base is equipped with professional testing equipment for quality inspection and control, laying a solid foundation for ensuring product quality. Ulipristal Acetate API powder is popular among domestic and foreign production enterprises and highly praised by users.
Specifications
Item | Specification | Results |
Appearance | White to off-white powder | Conforms |
Identification | HPLC retention time of sample | Conforms |
Water | ≤0.5% | 0.03% |
Residul solvents | ≤0.5% | 0.02% |
Resdual on ignition | ≤0.5% | 0.20% |
Related substances | PGAI: ≤0.5% | Undetected |
Assay | 98.0% ~ 105.0% | 99.98% |
Conclusion:Conform with USP42 specification . | ||
Why Choose Us?
Our production strictly follows the requirements of pharmaceutical production management standards, ensuring that each batch of products has extremely high purity, consistency, and stability. Having advanced production facilities and large-scale production capacity, we can ensure long-term, stable, and large-scale supply to meet your needs at all stages from research and development to commercialization. By adopting industry-leading and continuously optimized synthesis and purification processes, we have achieved more competitive production costs while ensuring top-notch quality. Multi channel transportation ensures safe delivery for you.
Main applications
Ulipristal Acetate is a selective progesterone receptor modulator, and Ulipristal Acetate API powder is mainly used in the production of the following terminal formulations:
- Emergency contraception: used for unprotected sex or emergency contraception after contraceptive failure (within 120 hours), with an effective window longer than traditional Levonorgestrel drugs.
- Uterine fibroid treatment: Used to treat moderate to severe symptoms of uterine fibroids in adult women of childbearing age. It can effectively control fibroid growth, reduce bleeding, and alleviate related pain by regulating progesterone receptors.
- Endometriosis management: Approved in some regions for the management of endometriosis, to alleviate symptoms such as pain caused by it.
- Other potential gynecological indications: In clinical studies, it has also shown potential for application in the treatment of other hormone dependent gynecological diseases, such as certain types of excessive menstruation.
if you need it , you can click here
Quality Control:

R&D Results:

Packaging and Transportation:

After-Sales Service:
Qualification Certification:

Exhibition:
FAQ
Q1:Where is Prostaglandin E1 metabolized?
A1:Prostaglandin E1 mainly oxidizes the hydroxyl group at position 15 of Prostaglandin E1 to a ketone group through 15 hydroxydeaminase (PGDH), causing it to lose physiological activity, and then undergoes a series of changes to form metabolic end products. 15 hydroxydeaminase (PGDH) is widely present in lung, liver, kidney, and adipose tissue, and it is generally believed that over 80% of Prostaglandin E1 is inactivated in the lungs.
Q2:What is the difference between the targeting of PGE1 API powder and tumor targeted drugs?
A2:PGE1 API powder is passively targeted, while tumor targeting drugs are actively targeted. When inflammatory lesions occur in blood vessels, blood vessels harden, or blood vessels spasm, blood flow changes from normal to abnormal, and PGE1 API powder is easily deposited at the site of vascular lesions, exerting its therapeutic effect.
Q3:Does PGE1 API powder inhibit platelet aggregation and cause bleeding?
A3: PGE1 API powder does not affect the reduction of platelet count or the coagulation mechanism of patients while inhibiting platelet aggregation. It won't cause bleeding.
Contact Us
We are not only manufacturers of active pharmaceutical ingredients, but also your trusted strategic partner. If you are intrested in our Ulipristal Acetate API powder,pls send message to sales12@faithfulbio.com.




